Clinical Trials Directory

Trials / Completed

CompletedNCT00995163

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease

Mineral and Bone Disorders Outcomes Study for Japanese Chronic Kidney Disease Stage 5D Patients (MBD-5D)

Status
Completed
Phase
Study type
Observational
Enrollment
8,020 (actual)
Sponsor
Kyowa Kirin Co., Ltd. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The MBD-5D is a prospective observational study with a case-cohort and a cohort design. Eligible patients are receiving hemodialysis and have secondary hyperparathyroidism. The study's three goals are (1) to record the patients' characteristics, and variation in the patterns of their treatment; (2) to analyze factors associated with variation in those medical practice patterns; and (3) to identify practice patterns and other factors that affect hospitalization, mortality, and other patient-level outcomes.

Detailed description

The MBD-5D is a 3-year prospective observational study with a case-cohort and a cohort design. Eligible patients comprise all patients who are receiving hemodialysis at the participating facilities, and who also have secondary hyperparathyroidism(2HPT). The study has 3 goals: to record the characteristics of those patients and variation in the patterns of their treatment; to analyze factors associated with variation in those medical practice patterns; and to identify the practice patterns and other factors that affect hospitalization, mortality, and other patient-level outcomes. In the case-cohort study, the outcomes are relatively infrequent events (all-cause and cardiovascular mortality). The cohort study includes a randomly selected sample of 40% of all study participants; and the outcomes are hospitalization, parathyroid interventions, bone fracture, MBD management status, etc. Explanatory variables comprise medications and other factors likely to be associated with outcomes of dialysis and of 2HPT, and facility-level practice patterns.

Conditions

Timeline

Start date
2008-01-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2009-10-15
Last updated
2012-08-23

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00995163. Inclusion in this directory is not an endorsement.